Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
$0.60 B
Marketcap
$17.38
Share price
-0.91%
Change (1 day)
-46.98%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): $0.50

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is $0.50. In 2025 the company made an earnings per share (EPS) of $0.74 an increase over its 2024 EPS that were of $0.61.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$0.50-31.85%
2025$0.7421.69%
2024$0.6121.02%
2023$0.50